Safety Thumbs Up For Zynteglo Prompts Bluebird To Lift Marketing Suspension

US Filing For The β-Thalassemia Gene Therapy Is On Track

Gene therapy concept.
Zynteglo gene therapy is going back on the EU market • Source: Alamy

More from Drug Safety

More from Pink Sheet